WEBINAR: Efficient Patient Identification in ALS Clinical Trials; Leveraging the Concept of Fast and Slow Progressors.

In collaboration with our partner TRICALS, we presented the webinar:
Efficient Patient Identification in ALS Clinical Trials; ​Leveraging the Concept of Fast and Slow Progressors.​

During this webinar Prof. Dr. L.H. van den Berg and Dr. R.P.A. van Eijk (UMC Utrecht, the Netherlands) talked about disease heterogeneity and the use of prediction-based patient selection in ALS clinical trials.

Other subjects that were adressed:
> Prediction-based inclusion criteria
> Defining the concept of fast vs slow progressors
> Addressing disease heterogeneity and reduce variance
> Regulatory perspective (EMA) on prediction-based patient selection

Wacth the replay now.
(webinar starts at 6:56)

More information about TRICALS, you will find below.